Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Cryptos Slide After A Brilliant Rally
  2. NIO Up 8% On Improved Quarterly Sales
  3. The Spot Bitcoin ETF Dream Shelved as More Regulatory Obstacles Block Approval
  4. Fitch Fitch's US Credit Rating Downgrade: How It Could Impact Bitcoin US Credit: How It Might Impact Bitcoin – Analyst Insight
  5. Markets Cheer U.S. GDP Data While Waiting For Jackson Hole Cues